L-Arginine in coronary atherosclerosis

被引：24
|
作者：
Tentolouris, C
Tousoulis, D
Goumas, G
Stefanadis, C
Davies, G
Toutouzas, P
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Unit, GR-11527 Athens, Greece
[2] Imperial Coll, Sch Med, Hammersmith Hosp, Cardiol Unit, London, England
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2000年 / 75卷 / 2-3期
关键词：
endothelium; nitric oxide; atherosclerosis; L-arginine;
D O I：
10.1016/S0167-5273(00)00320-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nitric oxide is formed from the N-guanido terminal of the amino acid L-arginine and from molecular oxygen by nitric oxide synthase enzymes. L-arginine administration improves the coronary blood flow response to acetylcholine in patients with normal coronary arteries and hypercholesterolemia, reverses the defective endothelium-dependent vasodilation associated with an elevated plasma low-density lipoprotein level or hypercholesterolemia, dilates coronary epicardial arteries and stenoses, enhances nitric oxide generation, and inhibits lesion formation after balloon angioplasty. Stimulation of endogenous nitric oxide production could inhibit atherogenesis, and therefore may be of benefit in patients with risk factors for atherosclerosis. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：123 / 128
页数：6
相关论文
共 50 条
  • [31] L-Arginine or agmatine?
    Wohlrab, J
    HAUTARZT, 2004, 55 (07): : 689 - 690
  • [32] The pharmacodynamics of L-arginine
    Boeger, Rainer H.
    JOURNAL OF NUTRITION, 2007, 137 (06): : 1650S - 1655S
  • [33] L-arginine oxalates
    Petrosyan, A. M.
    Sukiasyan, R. P.
    Karapetyan, H. A.
    Antipin, M. Yu.
    Apreyan, R. A.
    JOURNAL OF CRYSTAL GROWTH, 2005, 275 (1-2) : E1927 - E1933
  • [34] The Pharmacodynamics of L-Arginine
    Boeger, Rainer H.
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2014, 20 (03) : 48 - 54
  • [35] L-arginine nitrates
    Terzyan, SS
    Karapetyan, HA
    Sukiasyan, RB
    Petrosyan, AM
    JOURNAL OF MOLECULAR STRUCTURE, 2004, 687 (1-3) : 111 - 117
  • [36] L-arginine and hypertension
    Gokce, N
    JOURNAL OF NUTRITION, 2004, 134 (10): : 2807S - 2811S
  • [37] L-arginine and atherothrombosis
    Loscalzo, J
    JOURNAL OF NUTRITION, 2004, 134 (10): : 2798S - 2800S
  • [38] Effects of chronic oral L-arginine administration on the L-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: L-Arginine prevents renal loss of nitrite, the major NO reservoir
    Schneider, Jessica Y.
    Rothmann, Sabine
    Schroeder, Frank
    Langen, Jennifer
    Luecke, Thomas
    Mariotti, Francois
    Huneau, Jean Francois
    Froelich, Juergen C.
    Tsikas, Dimitrios
    AMINO ACIDS, 2015, 47 (09) : 1961 - 1974
  • [39] Effects of chronic oral l-arginine administration on the l-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: l-Arginine prevents renal loss of nitrite, the major NO reservoir
    Jessica Y. Schneider
    Sabine Rothmann
    Frank Schröder
    Jennifer Langen
    Thomas Lücke
    François Mariotti
    Jean François Huneau
    Jürgen C. Frölich
    Dimitrios Tsikas
    Amino Acids, 2015, 47 : 1961 - 1974
  • [40] ATTENUATION OF ACETYLCHOLINE-INDUCED VASOCONSTRICTION BY L-ARGININE IS RELATED TO THE PROGRESSION OF ATHEROSCLEROSIS
    OTSUJI, S
    NAKAJIMA, O
    WAKU, S
    KOJIMA, S
    HOSOKAWA, H
    KINOSHITA, I
    OKUBO, T
    TAMOTO, S
    TAKADA, K
    ISHIHARA, T
    OSAWA, N
    AMERICAN HEART JOURNAL, 1995, 129 (06) : 1094 - 1100
12345